Capital Markets

In an age of AI traders and instant data, one expert argues that the most valuable asset remains timeless: human discipline. But is this enough to navigate our volatile future?

BlackRock Canada is shifting five iShares ETFs to new indices, updating the core methodology to include intangibles and buybacks, a move expected to create capital gains.

NeoGenomics is raising $275M via convertible notes. We dissect the sophisticated financing, from dilution-hedging calls to the market impact for investors.

Apollo's REIT is liquidating after a strategic review. Is this an isolated move or a bellwether for distress in the commercial real estate finance sector?

The financial giant sets its 2027 Investor Day. Beyond the date, it's a signal of intent for navigating a fractured world with a $4.9T balance sheet.

Adaptive Biotechnologies' new debt offering is more than a financial tune-up; it's a calculated move to sever a costly royalty deal and arm its star MRD division for a separate future.

AIRA ushers in new leadership with Boris Steffen as President, poised to navigate economic turbulence and shape the future of the insolvency profession.

CrowdStrike's new Continuous Identity platform isn't just a product; it's a foundational shift for securing the coming wave of autonomous AI agents.

Calgary's Douglas Vermeeren faces new fraud charges despite a 10-year ban. His case reveals a high-stakes battle between regulators and persistent predators.

Anchorage Digital's custody of tokenized CETES marks a milestone, creating a federally regulated blueprint for bringing real-world sovereign debt onto the blockchain.

The Defiance 2X Space ETF was halted amidst the SpaceX IPO frenzy, revealing the extreme volatility and complex risks of new leveraged financial products.

A landmark CFTC approval for Kalshi and a key Haruko integration have finally unlocked the massive perpetual futures market for US institutions, heralding a new era.

With over 4.6% of all ETH, Bitmine is not just mining crypto; it's engineering a new kind of financial institution. Is its high-stakes strategy genius or hubris?

After its landmark IPO, Action Energy Co. is moving to stabilize its stock. We explore how this technical move signals a new era for investors in Kuwait.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

With audited reserves and public funds, exchanges are pushing for transparency. We dive deep into whether this new model for accountability can truly secure your assets.

The collateral management firm appoints a new CPO and promotes key execs, signaling a foundational shift to build autonomous AI-native products.

A new partnership aims to move beyond static risk models by integrating real-time news sentiment, giving firms a crucial edge in navigating market volatility.

Northern Trust's new Dublin banking license is more than expansion; it's a calculated response to strict new EU regulations and a major win for Ireland.

SKHTU Exchange touts a localized push for a Malaysian crypto license. But as it courts one of Asia's top regulators, a trail of questionable claims casts a shadow.